<DOC>
	<DOCNO>NCT00857467</DOCNO>
	<brief_summary>This healthy volunteer three-way crossover study . A total 12 subject receive three single administration 1 g rectal suppository ( contain either 5 mg NRL001 , 10 mg NRL001 match placebo ) , washout period least 7 day dosings . A 12 subject receive three single administration 2 g rectal suppository ( contain either 5 mg NRL001 , 10 mg NRL001 match placebo ) , 7 day washout period dosings . The pharmacodynamic response , pharmacokinetics safety profile determine .</brief_summary>
	<brief_title>Study Investigate Safety Response 1 2 g Rectal Suppositories Containing 5 10 mg NRL001 .</brief_title>
	<detailed_description />
	<mesh_term>Fecal Incontinence</mesh_term>
	<criteria>1 . No previous history anorectal condition diseases 2 . No history cardiovascular disease 3 . 18 60 year age 4 . Males female ( premenopausal female childbearing potential must use adequate contraceptive method negative pregnancy test start study ) 1 . Use medication last 30 day vasodilatory activity , use medication currently within last 30 day Investigator believe may affect study participation result 2 . Use monoamine oxidase inhibitor presently within last 2 week study participation 3 . Use medication last 30 day apply anus and/or via rectum 4 . Application unlicensed medication within previous 3 month participation research study last three month involve pay disturbance allowance ; invasive procedure ( e.g . venepuncture &gt; 50ml , endoscopy ) exposure ionise radiation . 5 . Regular intake 21 unit alcohol per week 6 . History evidence cardiovascular disease include ischaemic heart disease hypertension ( define examination : systolic blood pressure great 160 mmHg diastolic blood pressure great 90 mmHg ; base least two separate reading ) , peripheral vascular disease Raynaud 's syndrome 7 . Presence diabetes mellitus 8 . History symptom thyroid disease , include hypo hyperthyroidism 9 . Pregnant lactating female 10 . History clinically relevant allergy 11 . Presence concomitant gastrointestinal disease disorder , significant abdominal symptom haemorrhoid also significant organ ( e.g . renal , hepatic cardiac ) dysfunction 12 . Volunteers Investigator feel would comply requirement trial 13 . Volunteers expose 5 mSv ionise radiation last 12 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>